Dual market structures and the likelihood of repeated ties-evidence from pharmaceutical biotechnology

Article Abstract:

A study on research and development partnerships of pharmaceutical industry is presented. The effect of dual market structure in the industry made up of large high-tech pharmaceutical biotechnology firms on the one hand and a group of small firms dependent on the large firms on the other hand, on these research partnerships is analyzed.

Netherlands, Marketing procedures, Pharmaceutical preparations, Alliances, partnerships, Pharmaceutical industry, Marketing, Company marketing practices, Research agreements

---

University-industry interactions in applied research: the case of microelectronics

Article Abstract:

The need for universities to collaborate with industries so as to ensure high scientific performance, with reference to the case of microelectronics is discussed.

Canada, Case studies, Economic aspects, Creative ability in science, Scientific creativity, Miniature electronic equipment, Microelectronics

---

Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: trends, patterns, and networks

Article Abstract:

Trends in research collaborations in the pharmaceutical biotechnology industry from 1975 are analyzed.

United States, Drugs, Research, Analysis, Biotechnology industry, Biotechnology industries, Pharmaceutical research

Similar abstracts:

• Abstracts: Why are some university researchers more likely to create spin-offs than others? Evidence from Canadian universities
• Abstracts: Pac-Man metaphysics and the modest hubris of the professional intellectual. Rapid discovery, crossbreeding networks, and the scientific revolution
• Abstracts: Institutionalized biases in the award of research grants: a preliminary analysis revisiting the principle of accumulative advantage
• Abstracts: Competing urban visions and the shaping of the digital city
• Abstracts: Models for Organizing Health Services and Implications of Legislative Proposals. part 2 Representing Consumer Interests: Imbalanced Markets, Health Planning, and the HSAs

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.